Cutting Edge: Loss of α4 Integrin Expression Differentially Affects the Homing of Th1 and Th17 Cells
Open Access
- 15 December 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 187 (12) , 6176-6179
Abstract
The neutralization of α4 integrin is currently used as treatment in several autoimmune diseases and is thought to prevent the entry of most immune cells in target tissues. In this study, we showed that selective deletion of α4 integrin in T cells did not prevent but delayed the development of experimental autoimmune encephalomyelitis. Whereas both Th1 and Th17 cells infiltrate the CNS of wild-type mice, T cells present in the CNS of mice lacking α4 integrin were mainly enriched in Th17 cells, suggesting that this T cell subset uses other integrins to access the CNS. In contrast, α4 integrin expression is important for Th1 cells to enter the CNS and for the stability of their Th1-associated genetic program. Therefore, our data suggest that anti-α4 integrin Ab treatment may be more efficient in the treatment of Th1- rather than Th17-mediated disease.Keywords
This publication has 19 references indexed in Scilit:
- Th1 versus Th17: Are T cell cytokines relevant in multiple sclerosis?Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Fate mapping of IL-17-producing T cells in inflammatory responsesNature Immunology, 2011
- TET inducible expression of the α4β7‐integrin ligand MAdCAM‐1 on the blood–brain barrier does not influence the immunopathogenesis of experimental autoimmune encephalomyelitisEuropean Journal of Immunology, 2011
- T cells in multiple sclerosis and experimental autoimmune encephalomyelitisClinical and Experimental Immunology, 2010
- T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitisNature Medicine, 2010
- Phenotypical and functional characterization of T helper 17 cells in multiple sclerosisBrain, 2009
- Natalizumab for Multiple SclerosisNew England Journal of Medicine, 2007
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006
- IMMUNOLOGY OF MULTIPLE SCLEROSISAnnual Review of Immunology, 2005
- IntegrinsCell, 2002